Matching articles for "Flolipid"
Issue 1756 · June 8, 2026
Drugs for Hypercholesterolemia

Recently published multisociety guidelines for the management of dyslipidemia emphasize early identification and treatment of dyslipidemia to reduce the lifetime risk of atherosclerotic cardiovascular disease…

Med Lett Drugs Ther. 2026 Jun 8; 68(1756):89-95 doi:10.58347/tml.2026.1756a
Recently published multisociety guidelines for the management of dyslipidemia emphasize early identification and treatment of dyslipidemia to reduce the lifetime risk of atherosclerotic cardiovascular disease (ASCVD) and death.
Issue 1756 · June 8, 2026
Comparison Chart: Statins (online only)

View the Comparison Chart: Statins

Med Lett Drugs Ther. 2026 Jun 8; 68(1756):e94-5 doi:10.58347/tml.2026.1756b
View the Comparison Chart: Statins
Issue 1659 · September 19, 2022
Comparison Table: Some Lipid-Lowering Drugs (online only)

View the Comparison Table: Some Lipid-Lowering Drugs

Med Lett Drugs Ther. 2022 Sep 19; 64(1659):e152-6
View the Comparison Table: Some Lipid-Lowering Drugs
Issue 1595 · April 6, 2020
Bempedoic Acid (Nexletol) for Lowering LDL-Cholesterol

The FDA has approved the oral adenosine triphosphate-citrate lyase (ACL) inhibitor bempedoic acid for use alone ( Nexletol – Esperion) and in a fixed-dose combination with the cholesterol absorption…

Med Lett Drugs Ther. 2020 Apr 6; 62(1595):53-5
The FDA has approved the oral adenosine triphosphate-citrate lyase (ACL) inhibitor bempedoic acid for use alone ( Nexletol – Esperion) and in a fixed-dose combination with the cholesterol absorption inhibitor ezetimibe (Nexlizet) as an adjunct to diet and maximally tolerated statin therapy in adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-cholesterol (LDL-C). Bempedoic acid is the first ACL inhibitor to be approved in the US.
Issue 1581 · September 23, 2019 Free
Expanded Table: Statins (online only)

View the Expanded Table: Statins

Med Lett Drugs Ther. 2019 Sep 23; 61(1581):e152
View the Expanded Table: Statins
Issue 1565 · February 11, 2019
Lipid-Lowering Drugs

Cholesterol management guidelines from the American College of Cardiology/American Heart Association Task Force have recently been published. See Table 1 for a brief summary of their recommendations.

Med Lett Drugs Ther. 2019 Feb 11; 61(1565):17-24
Cholesterol management guidelines from the American College of Cardiology/American Heart Association Task Force have recently been published. See Table 1 for a brief summary of their recommendations.
Issue 1565 · February 11, 2019
Expanded Table: Lipid-Lowering Drugs (online only)

View the Expanded Table: Lipid-Lowering Drugs

Med Lett Drugs Ther. 2019 Feb 11; 61(1565):e24-30
View the Expanded Table: Lipid-Lowering Drugs